Education
About Us
Working with TipRanks
Follow Us
Matthew Posard Insider Profile
4 Followers
Matthew Posard, CCO at Cardiff Oncology, holds 74.04K shares in Halozyme (Ticker: HALO), holds 158.22K shares in DermTech (Ticker: DMTKQ), holds 150.00K shares in Nautilus Biotechnolgy (Ticker: NAUT).
Profitable Transactions
1 out of 4 Profitable Transactions
Average Return
-46.20%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Posard holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Posard
Matthew Posard's Trading History
Cardiff Oncology
Aug 24, 2015
CCO
Uninformative Buy
―
$28.35K
DermTech
Jun 05, 2023
―
Uninformative Buy
―
$3.16K
Talis Biomedical
Feb 19, 2021
―
Informative Buy
1.00M
$177.50K
Nautilus Biotechnolgy
Dec 01, 2021
Director
Informative Buy
225.40K
$361.50K
Halozyme
May 02, 2025
Director
Uninformative Buy
―
$5.14M
Illumina
May 30, 2013
Sr VP & General Manager
Uninformative Sell
200.79K
$4.00M
List of latest transactions for each holding click on a transaction to see Matthew Posard's performance on stock
You May Also Like
Matthew Posard insider profile FAQ
What is the percentage of profitable transactions made by Matthew Posard?
The percentage of profitable transactions made by Matthew Posard is 25%.
What is the average return per transaction made by Matthew Posard?
The average return per transaction made by Matthew Posard is -46.20%.
What stocks does Matthew Posard hold?
Matthew Posard holds: CRDF, DMTKQ, TLIS, NAUT, HALO, ILMN stocks.
What was Matthew Posard’s latest transaction?
Matthew Posard latest transaction was an Uninformative Buy of ―.
What was Matthew Posard's most profitable transaction?
Matthew Posard’s most profitable transaction was an Informative Sell of HALO stock on December 6, 2022. The return on the trade was 29.10%.
What is Matthew Posard's role in Cardiff Oncology?
Matthew Posard's role in Cardiff Oncology is CCO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.